The U.S. Food and Drug Administration (FDA) announced its plans to end the mandatory animal testing of new drugs, a move that sent AI-enabled biotech companies such as Recursion Pharmaceuticals Inc.
(RTTNews) - November, a month best known for Thanksgiving and harvest festivals, is also an important month for raising awareness about various health issues. Some of the key health observances in ...
Late-stage biopharma Scholar Rock (SRRK) is approaching a pivotal catalyst: the FDA decision on apitegromab, its investigational muscle-targeted therapy for spinal muscular atrophy (SMA). A verdict is ...
OMAHA AND COUNCIL BLUFFS ANY DAY NOW IN OMAHA, WOMAN EXPECTS A DECISION FROM THE FDA. SHE SAYS IT WILL DECIDE WHETHER HER SON LIVES OR DIES. LAST MONTH, KETV NEWSWATCH SEVEN’S ERIN HAGERTY BROUGHT YOU ...
WASHINGTON, Aug. 21, 2025 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (VNDA) today announced that it has asked Martin Makary, the Commissioner of the U.S. Food and Drug Administration (FDA) to review ...
UroGen Pharma Ltd.'s investment thesis hinges on FDA approval of UGN-102, a minimally invasive bladder cancer treatment with a June 13 decision date. ODAC narrowly voted against approval, citing ...
(RTTNews) - May has just begun, and it's time to turn our attention to the FDA decisions on deck for the coming weeks. So far this year, the U.S. regulatory agency has approved only nine novel drugs - ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback